Japan Multinational Trial Organization

Quick facts

Phase 3 pipeline

• kanamycin/metronidazole · Infectious disease
  Kanamycin is an aminoglycoside antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit, while metronidazole is an antimicrobial agent that kills bacteria by interfering with DNA replication.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Japan Multinational Trial Organization portfolio CI brief
• Japan Multinational Trial Organization pipeline updates RSS